Pharming Group N.V. (PHAR) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-03-12 15:12:21 ET
Pharming Group N.V. (PHAR) Q4 2025 Earnings Call March 12, 2026 8:30 AM EDT
Company Participants
Fabrice Chouraqui - CEO & Executive Director
Leverne Marsh - Chief Commercial Officer
Anurag Relan - Chief Medical Officer
Kenneth Lynard - Chief Financial Officer
...
Read the full article on Seeking Alpha
For further details see:
Pharming Group N.V. (PHAR) Q4 2025 Earnings Call Transcript
Pharming Group N.V.
NASDAQ: PHAR
PHAR Trading
0.27% G/L:
$13.12 Last:
8,811 Volume:
$13.24 Open:
PHAR Latest News
$1,106,258,522
65,794,170
N/A
5
N/A
Biotechnology & Life Sciences
Healthcare
NL
Leiden
